Please try another search
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally. It offers functional raw materials, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikangwei C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Name | Age | Since | Title |
---|---|---|---|
Bing Yao | - | 2023 | Non-Independent Director |
Dibin Li | - | 2023 | Independent Director |
Dong Yang | - | 2023 | Non-Independent Director |
Peng Yang | - | 2023 | Independent Director |
Congzhi Di | - | 2023 | Independent Director |
Ling Zhang | - | 2023 | Non-Employee Supervisor |
Jiyong Zhang | - | 2023 | Non-Employee Supervisor |
Weidong Pan | 53 | 2023 | Chairman |
Lei Cai | 43 | 2023 | Non-Independent Director |
Feng Han | 49 | 2023 | GM & Director |
Huaiyu Wang | 60 | 2020 | Non-Independent Director |
Bing Yuan | 52 | 2020 | Employee Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review